Biolab expands international footprint with acquisition of Canadian company

We are very happy to share Biolab’s new acquisition, the Canadian company Exzell Pharma. Biolab expanded to Canada in 2017 with a research and development facility. In this first phase, the priorities were to understand the legislation and the product registration process, in addition to certifying the company’s plants in Brazil for export – the Jandira and Bragança Paulista plants have already achieved certification. The company is now progressing toward the global market with the purchase of the Canadian laboratory Exzell Pharma, located in Markham, Ontario.